5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Mitral Valve
The mitral valve, situated in the heart, plays a crucial role in maintaining proper blood flow. Positioned between the left atrium and the left ventricle, this bicuspid valve facilitates the unidirectional flow of oxygenated blood from the atrium to the ventricle during each heartbeat. The mitral valve consists of two flaps, or leaflets, which open and close synchronously to ensure efficient blood circulation. Any disruption in the normal functioning of the mitral valve, such as mitral valve prolapse or stenosis, can impact cardiac performance. Clinicians often monitor the mitral valve's health as part of cardiovascular assessments, and treatments may range from medication to surgical interventions, depending on the severity of the condition. Understanding the significance of the mitral valve underscores its importance in maintaining the intricate balance of the circulatory system.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain